These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25946369)

  • 41. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study.
    Hechter RC; Chao C; Jacobsen SJ; Slezak JM; Quinn VP; Van Den Eeden SK; Tseng HF
    Vaccine; 2012 Aug; 30(38):5625-30. PubMed ID: 22789510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pneumococcal vaccination.
    de Roux A; Lode H
    Eur Respir J; 2005 Dec; 26(6):982-3. PubMed ID: 16319323
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression.
    Jordan N; Lee TA; Valenstein M; Weiss KB
    J Gen Intern Med; 2007 Oct; 22(10):1447-52. PubMed ID: 17687614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: a multimodal pilot project.
    Nowalk MP; Nutini J; Raymund M; Ahmed F; Albert SM; Zimmerman RK
    Vaccine; 2012 Sep; 30(41):5978-82. PubMed ID: 22835736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries.
    Davis KJ; Landis SH; Oh YM; Mannino DM; Han MK; van der Molen T; Aisanov Z; Menezes AM; Ichinose M; Muellerova H
    Int J Chron Obstruct Pulmon Dis; 2015; 10():39-55. PubMed ID: 25565799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines.
    Ta M; George J
    Intern Med J; 2011 Mar; 41(3):263-70. PubMed ID: 20002857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Assessment of primary care physicians' adherence to the national childhood vaccination schedule].
    Pruvost I; Lowingerova-Fauvet S; Debacker P; Dervaux B; Dubos F; Martinot A
    Arch Pediatr; 2012 Mar; 19(3):248-53. PubMed ID: 22264997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD.
    Santos-Sancho JM; Jimenez-Trujillo I; Hernández-Barrera V; López-de Andrés A; Carrasco-Garrido P; Ortega-Molina P; Jiménez-García R
    Hum Vaccin Immunother; 2012 Jul; 8(7):938-45. PubMed ID: 22485047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.
    Chavez PC; Shokar NK
    COPD; 2009 Dec; 6(6):446-51. PubMed ID: 19938968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
    Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
    Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Estimates of Target Population for Pneumococcal Vaccination in People over 50 years in Catalonia and Spain].
    Vila-Córcoles A; Ochoa-Gondar O; Satué E; de Diego C; Vila-Rovira M; Jariod M
    Rev Esp Salud Publica; 2017 Mar; 91():. PubMed ID: 28300793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011.
    de Souto Barreto P; Lapeyre-Mestre M; Vellas B; Rolland Y
    Vaccine; 2014 Feb; 32(7):846-51. PubMed ID: 24370710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of hospitalizations for COPD exacerbation: opportunities for improving care.
    Yip NH; Yuen G; Lazar EJ; Regan BK; Brinson MD; Taylor B; George L; Karbowitz SR; Stumacher R; Schluger NW; Thomashow BM
    COPD; 2010 Apr; 7(2):85-92. PubMed ID: 20397808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period.
    Ting SC; Crooks SW; South G
    J Epidemiol Community Health; 2011 Feb; 65(2):157-9. PubMed ID: 19996358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management.
    Menezes AM; Landis SH; Han MK; Muellerova H; Aisanov Z; van der Molen T; Oh YM; Ichinose M; Mannino DM; Davis KJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():159-72. PubMed ID: 25653515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disparities in pneumococcal and influenza immunization among older adults in Israel: a cross-sectional analysis of socio-demographic barriers to vaccination.
    Wershof Schwartz A; Clarfield AM; Doucette JT; Valinsky L; Karpati T; Landrigan PJ; Sternberg SA
    Prev Med; 2013 May; 56(5):337-40. PubMed ID: 23402962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantification of inaccurate diagnosis of COPD in primary care medicine: an analysis of the COACH clinical audit.
    Abad-Arranz M; Moran-Rodríguez A; Mascarós Balaguer E; Quintana Velasco C; Abad Polo L; Núñez Palomo S; Gonzálvez Rey J; Fernández Vargas AM; Hidalgo Requena A; Helguera Quevedo JM; García Pardo M; Lopez-Campos JL
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1187-1194. PubMed ID: 31239656
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.
    Ciruela P; Soldevila N; Hernández S; Selva L; de Sevilla MF; García-García JJ; Moraga F; Planes AM; Muñoz-Almagro C; Domínguez A
    Vaccine; 2013 Jan; 31(6):960-6. PubMed ID: 23261046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).
    Díez-Domingo J; Ridao-López M; Gutiérrez-Gimeno MV; Puig-Barberá J; Lluch-Rodrigo JA; Pastor-Villalba E
    Vaccine; 2011 Dec; 29(52):9640-8. PubMed ID: 22027484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.